Navigation Links
Publicis Healthcare Communications Group Redefines Publicis Groupe's Healthcare Client Offering by Joining Forces with Digitas Health and Razorfish Health
Date:10/27/2011

amed Medical Marketing & Media's Agency of the Year. Today, Digitas Health is one of the most successful healthcare marketing and media agencies in the world.  Razorfish Health was created in 2010 to meet the growing demand of healthcare clients for cutting-edge digital and technology solutions. Both agencies are headquartered in Philadelphia, and have locations in New York, Boston, and London. Among their top clients are AstraZeneca, Pfizer, Bristol-Myers Squibb, Shire, Novo Nordisk, and Johnson & Johnson.  

 "We are thrilled to welcome Digitas Health and Razorfish Health to PHCG," said Nick Colucci. "Our clients, first and foremost, are the greatest beneficiaries of this move. They will find enhanced global access and innovation, alongside the best healthcare communications talent in the world, within a true network created by the partnership of Digitas Health and Razorfish Health with the other PHCG agencies."

Laura Lang, Global CEO of Digitas and executive lead of the VivaKi social, mobile and digital agencies said, "I am very proud of the phenomenal success of Digitas Health and Razorfish Health, largely due to their creative core, tenacious leadership and digital heritage.  While both agencies will continue to benefit from strong relationships at Digitas and VivaKi, I am confident that these two agencies will continue to thrive and contribute greatly to the future success of PHCG."

"Our clients are demanding global scale and networked solutions now," said Michael du Toit. "Joining forces with PHCG will give Digitas Health and Razorfish Health the greatest ability to meet the needs of consumer and professional marketers worldwide."

"Nick has made a strong commitment to innovation and to leading in the next era of healthcare marketing," Alexandra von Plato added. "Michael and I believe that by partnering with PHCG today we will be able to create more opportunity for our clients, our agencies, and our people
'/>"/>

SOURCE Publicis Groupe
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. ViroPharma to Present at Three Upcoming Healthcare Conferences
4. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
5. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
6. Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study
7. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference
8. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
9. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
10. Iomai CEO to Speak at Acumen BioFin Rodman & Renshaw Annual Healthcare Conference on Monday, Nov. 5
11. Immtech to Present at The Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... Research and ... of the "2015 New Frontiers in ... Technologies, Competitive Landscape" report to their ... Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging ... strategic analysis of major business opportunities emerging ...
(Date:7/2/2015)...  AbbVie (NYSE: ABBV ) will announce its ... before the market opens. AbbVie will host ... 8 a.m. Central time (9 a.m. Eastern). It will ... www.abbvieinvestor.com . An archived edition of the call will ... About AbbVie AbbVie is a global, research-based ...
(Date:7/2/2015)... -- Legal-Bay LLC, The Lawsuit Settlement Funding Company, announced ... in the Southern District of West Virginia ... Ethicon for a single trial to take place on ... women include claims from the women plaintiffs that they ... Johnson,s Ethicon subsidiary. The cases against Ethicon are among ...
Breaking Medicine Technology:New Frontiers in 2015 Global Clinical Chemistry and Immunodiagnostics Market: Challenges, Emerging Technologies, Competitive Landscape 2Judge Sets Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 2Judge Sets Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 3
... NEW YORK, July 14 Keryx Biopharmaceuticals, Inc. ... a Phase 1 clinical study to evaluate KRX-0401 (perifosine) as ... patients. This Phase 1 study is now open for enrollment ... Oren Becher, MD, Instructor, Department of Pediatrics, in coordination with ...
... TEL AVIV, Israel, July 14 ... EMITF ), announced today that, its subsidiary (in ... today,that a team at the University Children,s Hospital ... of non-invasive transcranial MR-guided,focused ultrasound surgery (TcMRgFUS) for ...
Cached Medicine Technology:Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center 2Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center 3Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center 4Elbit Imaging Ltd. Announces - Swiss Team Uses InSightec's ExAblate(R) 4000 Brain System to Treat Patients With Functional Brain Disorders 2Elbit Imaging Ltd. Announces - Swiss Team Uses InSightec's ExAblate(R) 4000 Brain System to Treat Patients With Functional Brain Disorders 3Elbit Imaging Ltd. Announces - Swiss Team Uses InSightec's ExAblate(R) 4000 Brain System to Treat Patients With Functional Brain Disorders 4
(Date:7/2/2015)... ... July 02, 2015 , ... AvePoint Public Sector, Inc., a wholly ... and devices, today announced it was named the recipient of the 2015 GTRA ConVurge ... given out by the Government Technology Research Alliance (GTRA), was presented June 29 during ...
(Date:7/2/2015)... ... ... arrests and fatalities spike on the 4th of July. In fact, because of drunk drivers, ... to being on the road. According to attorney David J. Maloney , the statistics ... deaths between 2007 and 2011 were caused by drunk driving over the 4th of July ...
(Date:7/2/2015)... Yorba Lind, CA (PRWEB) , ... July 02, 2015 , ... ... Dunne, PhD, QC manager, have adopted Lean methodology in their QC laboratory for enhanced ... Certified Lean Six Sigma Laboratory within the GE Healthcare Diagnostic Imaging network. ...
(Date:7/2/2015)... ... 2015 , ... As part of the celebration of its 70th anniversary, the ... its patients from all around the world for their continuous patronage of the world-class ... a dental tour (indeed, Thantakit is one of the foremost places for dental tourism ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... ... with nutritionally based weight-loss programs , was named No. 14 on ColoradoBiz ... this is the third year SlimGenics has been recognized. The award identifies outstanding ...
Breaking Medicine News(10 mins):Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 2Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 3Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 4Health News:Attorney David Maloney Stresses Safety through Sobriety 2Health News:GE Healthcare Webinar Spotlights GE’s Own, Internal QC Lab Enhancements with Six Sigma 2Health News:GE Healthcare Webinar Spotlights GE’s Own, Internal QC Lab Enhancements with Six Sigma 3Health News:Thailand's Longest Established International Dental Center Celebrates Its 70th Anniversary with Promos Galore 2Health News:ColoradoBiz Magazine Names SlimGenics #14 on Top 100 Woman-Owned Companies List 2Health News:ColoradoBiz Magazine Names SlimGenics #14 on Top 100 Woman-Owned Companies List 3
... , FRIDAY, Jan. 14 (HealthDay News) -- Researchers have ... risk of cardiovascular disease, while also noting that having ... once arteries become clogged. "Certain genes predispose to ... heart attack when you already have plaque build-up," said ...
... ongoing controversy about the appropriate age, frequency, and ... the upcoming 19th Annual Congress on Women,s Health, ... "Point-Counterpoint: The Mammography Controversy" will explore the relevant ... of Radiology, Magee-Womens Hospital, University of Pittsburgh School ...
... HealthDay Reporter , FRIDAY, Jan. 14 (HealthDay News) -- If ... you stand and sit may affect how you feel about ... an interview during these tough economic times, according to a ... Management at Northwestern University in Illinois found that undergraduates who ...
... -- Bacteria that prey on other bacteria may prove useful ... two types of predatory bacteria -- Micavibrio aeruginosavorus ... bacteria. "They actually have to consume other bacteria in ... ability to seek out other bacteria, invade them, grow in ...
... News) -- Obese black patients receive less weight reduction and ... study finds. The researchers at the Johns Hopkins University ... to find that white patients treated by black doctors were ... black patients treated by black doctors. "Our findings could ...
... , FRIDAY, Jan. 14 (HealthDay News) -- ... to become primary care doctors, who are expected to ... contends a new study from Johns Hopkins. They,re ... problems as diabetes, hypertension and high cholesterol, the study ...
Cached Medicine News:Health News:Blood Type O Associated With Less Risk for Heart Attack 2Health News:Blood Type O Associated With Less Risk for Heart Attack 3Health News:Mammography controversy to be explored at 19th Annual Congress on Women's Health 2Health News:To Nab That Job, Check Your Posture 2Health News:To Nab That Job, Check Your Posture 3Health News:Predatory Bacteria May Help Control Antibiotic-Resistant Germs 2Health News:Is Race a Factor in Obesity Counseling? 2Health News:Med School Grads May Not Be Ready for Primary Care 2
For the quantitative determination of total protein in serum. Linearity: 1-15 g/dl....
For the determination of urea nitrogen in human serum....
... for the quantitative determination of ... kinetic, lag phase of less ... linear phase of at least ... Linearity: 100 mg/dL (35.6 mmol/L ...
Intended for the quantitative determination of urea nitrogen in serum. Reaction: kinetic. Wavelength: 340 nm. Linearity: 150 mg/dL (53.4 mmol/L urea) at 37C....
Medicine Products: